Leflunomide is an immunomodulator with antineoplastic and antiviral potentials
g
The risk to develop lymphoma is doubled in patients with rheumatoid arthritis (RA) in the absence of immunosuppressive therapy
The reason why some patients develop lymphoma is
The inexpensive, well-tolerated, immunomodulatory agent leflunomide, used extensively for the treatment of rheumatoid arthritis, has been shown to produce
Leflunomide is a novel immunosuppressive compound that is effective in the treatment of animal models of autoimmune disease and human rheumatoid arthritis